A DNA vaccine based on a shuffled E7 oncogene of the human papillomavirus type 16 (HPV 16) induces E7-specific cytotoxic T cells but lacks transforming activity

By Osen W.   Peiler T.   Ohlschlager P.   Caldeira S.   Faath S.   Michel N.   Muller M.   Tommasino M.   Jochmus I.   Gissmann L.  

Vaccine, Vol. 19, Iss. 30, 2001-07 ,pp. : 4276-4286

Elsevier

Access to resources Recommend Favorite

Eradication of established HPV16-transformed tumours after immunisation with recombinant Semliki Forest virus expressing a fusion protein of E6 and E7

By Daemen T.   Riezebos-Brilman A.   Bungener L.   Regts J.   Dontje B.   Wilschut J.  

Vaccine, Vol. 21, Iss. 11, 2003-03 ,pp. : 1082-1088

Elsevier

Access to resources Recommend Favorite

Enhancement of human papillomavirus (HPV) type 16 E6 and E7-specific T-cell immunity in healthy volunteers through vaccination with TA-CIN, an HPV16 L2E7E6 fusion protein vaccine

By de Jong A.   O'Neill T.   Khan A.Y.   Kwappenberg K.M.C.   Chisholm S.E.   Whittle N.R.   Dobson J.A.   Jack L.C.   St Clair Roberts J.   Offringa R.   van der Burg S.H.   Hickling J.K.  

Vaccine, Vol. 20, Iss. 29, 2002-10 ,pp. : 3456-3464

Elsevier

Access to resources Recommend Favorite

Immunisation with modified HPV16 E7 genes against mouse oncogenic TC-1 cell sublines with downregulated expression of MHC class I molecules

By Smahel M.   Sma P.   Ludvkova V.   Marinov I.   Pokorna D.   Vonka V.  

Vaccine, Vol. 21, Iss. 11, 2003-03 ,pp. : 1125-1136

Elsevier

Access to resources Recommend Favorite

Antitumor efficacy of Venezuelan equine encephalitis virus replicon particles encoding mutated HPV16 E6 and E7 genes

By Cassetti M.C.   McElhiney S.P.   Shahabi V.   Pullen J.K.   Le Poole I.C.   Eiben G.L.   Smith L.R.   Kast W.M.  

Vaccine, Vol. 22, Iss. 3, 2004-01 ,pp. : 520-527

Elsevier

Access to resources Recommend Favorite